Legal Representation
Attorney
Craig M. Scott
USPTO Deadlines
Application History
37 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 11, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Feb 11, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Feb 4, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Nov 29, 2018 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| May 29, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 25, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 25, 2018 | EXT3 | S | SOU EXTENSION 3 FILED |
| May 25, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 29, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 27, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 27, 2017 | EXT2 | S | SOU EXTENSION 2 FILED |
| Nov 27, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jun 2, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 31, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| May 31, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 31, 2017 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 31, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED |
| May 5, 2017 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| May 1, 2017 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Apr 11, 2017 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Dec 27, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 1, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Nov 1, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 12, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 26, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Sep 20, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 1, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 1, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 25, 2016 | ALIE | A | ASSIGNED TO LIE |
| Aug 19, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 11, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 11, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 11, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 9, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
| Nov 21, 2015 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Nov 20, 2015 | NWAP | I | NEW APPLICATION ENTERED |
| Nov 20, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Detailed Classifications
Class 042
development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reactions, anaphylaxis or asthma
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the word "EPIZON" featuring a benzene ring as the "O" followed by the words "PHARMA, INC".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA, INC."